
Innovacap
Live Price
Recent news and updates for INNOVACAP will appear here soon.
"Caution advised for INNOVACAP investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors, stockists, and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
As of the latest market session, Innovacap (INNOVACAP) is trading at ₹1,049.7, representing a move of -1.21% from the previous close.
Innovacap is listed and traded under the ticker symbol INNOVACAP on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Innovacap's stock price moved by -1.21%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 35% bullish probability for INNOVACAP stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Innovacap shares reached a high of ₹1,353.5 and hit a low of ₹622.
INNOVACAP exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 17,597 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Innovacap has a market capitalization of ₹6006.90 Cr, designating its size class inside the Healthcare sector.
Innovacap has a current dividend yield of 40.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Innovacap's trailing Price-to-Earnings (P/E) ratio is 36.64. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Innovacap (INNOVACAP) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Innovacap's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore INNOVACAP's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for INNOVACAP are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Innovacap operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.